With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...
in particular hepatitis B surface-specific T cell responses. HBV-specific CD8 + T cells with different target specificities (HBV core epitope vs HBV polymerase (pol) epitope) are characterised by ...
Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in ... or HBV core antibody (anti-HBc). The most common cause of HBVr is prolonged ...
Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...
For patients at high risk of hepatitis B reactivation, AGA recommends preventive antiviral medication. Reactivated HBV can lead to liver damage, hospitalization, and even death.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results